Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03325764
Other study ID # HAO 017013
Secondary ID 2017-A01807-46
Status Completed
Phase N/A
First received
Last updated
Start date November 2, 2017
Est. completion date November 5, 2019

Study information

Verified date January 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to describe the effects of sleeve gastrectomy, the most commonly performed bariatric procedure worldwide, on functional capacity, habitual physical activity, physical fitness (cardiorespiratory and muscular fitness) and gait parameters in severely obese subjects undergoing bariatric surgery. Functional capacity, physical activity, physical fitness and gait parameters will be objectively assessed and compared among candidates seeking sleeve gastrectomy and 6 months after sleeve gastrectomy.


Description:

This study is a monocentric longitudinal study conducting in obese patients: candidates to sleeve gastrectomy and these same patients 6 months after.The primary aim of this study is to describe the effects of sleeve gastrectomy on habitual physical activity, physical fitness (cardiorespiratory and muscular fitness) and gait parameters in severely obese patients. Functional capacity will be assessed during a 6-min walk test, habitual physical activity with accelerometers during 7-day recordings in habitual life conditions (Actigraph GT3X® and activPAL®), cardiorespiratory fitness during a maximal exercise test on a cycle ergometer with a direct measure of peakVO2, muscle strength with an isokinetic dynamometer (Contrex®), muscle power and postural stability with force platforms (Kistler® and Satel®) and gait parameters with a gait analysis system (GaitRite®). Fatigue, quality of life and joint pain will be assessed with questionnaires (MFI-20, SF36 and WOMAC, respectively).


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date November 5, 2019
Est. primary completion date November 5, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Female gender - Age between 18 and 65 years - Planned obesity treatment by sleeve gastrectomy - Patient with massive obesity (BMI = 40 kg/m2) or severe obesity (BMI between 35 and 40 kg/m2) with comorbidities - Written informed consent Exclusion Criteria: - Subject not affiliated with a social security scheme - Regular follow-up not feasible - Participation in a structured physical activity program - Severe orthopedic problems - Disabling neuropathy - Recent (< 6 months) coronary event - Abnormal cardiac stress test - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
functional assessment
assessment of functional capacity, habitual physical, cardiorespiratory fitness, muscle power and postural stability and gait parameters

Locations

Country Name City State
France GH-Pitié-Salpêtrière Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary functional capacity Difference in functional capacity (6-min walk test distance) before and 6 months after sleeve gastrectomy
Secondary habitual physical activity (Actigraph GT3X® and activPAL®) Difference in habitual physical activity before and 6 months after sleeve gastrectomy
Secondary cardiorespiratory fitness ( cycle ergometer ) Difference in cardiorespiratory fitness before and 6 months after sleeve gastrectomy
Secondary muscle strength ( isokinetic dynamometer (Contrex®)) Difference in muscle strength before and 6 months after sleeve gastrectomy
See also
  Status Clinical Trial Phase
Terminated NCT03527810 - Hiatal Interrogation in Sleeve Gastrectomy N/A
Recruiting NCT06157606 - Prediction Model for Inadequate Weight Loss After Sleeve Gastrectomy
Completed NCT04082923 - Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric Surgery N/A
Recruiting NCT05856617 - Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients Phase 4
Withdrawn NCT03376399 - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
Completed NCT03440138 - Defining Benchmarks in Bariatric Surgery
Recruiting NCT05620641 - Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy Phase 3
Enrolling by invitation NCT04168060 - Crural Dissection in Sleeve Gastrectomy N/A
Recruiting NCT03467906 - Role of Dietary Habits in Efficacy of Bariatric Surgery - Study B
Recruiting NCT04237311 - Bariatric Surgery and Male Reproductive Function
Completed NCT03331536 - Skeletal Health in Bariatric Surgery Patients
Not yet recruiting NCT03070457 - Safety of an Early Discharge Protocol After Sleeve Gastrectomy N/A
Recruiting NCT05224791 - A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy
Recruiting NCT05452980 - Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients N/A
Recruiting NCT02823665 - The Effects of Bariatric Surgeries on Glucose Metabolism Early Phase 1
Recruiting NCT02210975 - An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients After Sleeve Gastrectomy N/A
Recruiting NCT05977790 - Determinant of Fetal Growth Retardation After Sleeve Gastrectomy: Involvement of Ghrelin
Recruiting NCT03776669 - Laparoscopic Sleeve Gastrectomy With or Without Hiatal Hernia Repair in Morbidly Obese Patients N/A
Recruiting NCT03891056 - Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT) N/A
Recruiting NCT05710263 - Bariatric Embolization Before Sleeve Gastrectomy for Super Obese Patients N/A